<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2020</study_start_year><condition>Diseases of the digestive system</condition><disease>Diseases Of The Digestive System</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2512718</full_dataset_link><location>South Korea</location><study_start_month>4</study_start_month><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>Efficacy and Safety of Bojungikgi-tang for Anorexia in Patients with Colorectal Cancer after Curative Resection and Chemotherapy : A single-arm, Open label, Single cencer Trial</name><description>Interventions: Drug : Participants will be administered Hanpoong Bojungikgi-tang at a dose of 75ml three times a day before or between meals for 6 weeks(42days)
Primary outcome(s): The Changes of Anorexia/cachexia subscale(A/CS) of Functional Assessment of Anorexia/Cachexia Therapy(FAACT)</description><dates><creation>2020-04-15</creation></dates><accession>2512718</accession><cross_references><Clinical Research Information Service>KCT0004785</Clinical Research Information Service></cross_references></HashMap>